Skip to main content

Hambleton Julie's Form 4 filing

SpringWorks Therapeutics, Inc.SWTX · filed Jun 5, 2024

Accession no.
0001104659-24-068674
Filed
Jun 5, 2024
Trade date
Jun 3, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions. Open-market sales total $186.0K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hambleton JulieCIK 0001578771Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 3, 2024Common StockSSaleDisposed−2,946$39.41F2−$116,101.865,797Direct
Jun 3, 2024Common StockSSaleDisposed−751$40.57F3−$30,468.075,046Direct
Jun 3, 2024Common StockSSaleDisposed−931$41.49F4−$38,627.194,115Direct
Jun 3, 2024Common StockSSaleDisposed−20$42.09F5−$841.84,095Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.02 to $40.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F3

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.02 to $40.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F4

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.02 to $42.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F5

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.06 to $42.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)